12:00 AM
Dec 21, 2009
 |  BC Week In Review  |  Company News  |  Deals

Almirall, Forest Laboratories deal

Almirall partnered with Forest to develop and commercialize Almirall's LAS100977 in the U.S. The once-daily long-acting adrenergic receptor beta 2 agonist (LABA) is in Phase...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >